Weisbrod Daniel J, Pavlin Charles J, Emara Khaled, Mandell Mark A, McWhae John, Simpson E Rand
Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada.
Am J Ophthalmol. 2006 Apr;141(4):622-8. doi: 10.1016/j.ajo.2005.11.006.
Detecting and following small tumors of the ciliary body is a particular challenge because of their location. Recently high-frequency ultrasound biomicroscopy (UBM) has been used to assist in this task. The aim of this study was to evaluate this subset of small ciliary body tumors through the use of UBM.
Retrospective, noncomparative case series.
Forty-two patients with small ciliary body tumors (less than 4 mm) from our institution were included in the study with a median follow-up of 4.3 years. UBM was used to assess tumor characteristics including height, location, and internal and external features. The data were collected longitudinally, and statistical analysis was performed.
Median initial tumor height was 2.05 mm (range 1.1 to 3.8 mm) as measured by UBM. By 5 years after diagnosis, five tumors (12%) exhibited growth. The overall mean growth rate was 0.026 mm per year (P = .00007). The most rapid period of growth was in the first year after diagnosis (growth rate 0.128 mm per year), after which the mean tumor size appeared to stabilize.
UBM is a valuable tool for detecting and following small ciliary body tumors (less than 4 mm), as these lesions may go undetected by other methods. Despite the potential for local extension into the iris or choroid, few of the tumors in this study exhibited growth, suggesting that many of these tumors can be managed conservatively. UBM can be used to assess various internal tumor features; however, arriving at a specific diagnosis without histologic correlation is difficult.
由于睫状体小肿瘤的位置特殊,检测和追踪它们是一项特殊的挑战。近年来,高频超声生物显微镜(UBM)已被用于辅助这项工作。本研究的目的是通过使用UBM来评估这一亚组的睫状体小肿瘤。
回顾性、非对照病例系列。
本研究纳入了我院42例睫状体小肿瘤(小于4mm)患者,中位随访时间为4.3年。使用UBM评估肿瘤特征,包括高度、位置以及内部和外部特征。纵向收集数据并进行统计分析。
通过UBM测量,初始肿瘤中位高度为2.05mm(范围1.1至3.8mm)。诊断后5年,5例肿瘤(12%)出现生长。总体平均生长率为每年0.026mm(P = 0.00007)。生长最快的时期是在诊断后的第一年(生长率为每年0.128mm),此后肿瘤平均大小似乎趋于稳定。
UBM是检测和追踪睫状体小肿瘤(小于4mm)的宝贵工具,因为这些病变可能无法被其他方法检测到。尽管存在局部延伸至虹膜或脉络膜的可能性,但本研究中很少有肿瘤出现生长,这表明许多此类肿瘤可以保守治疗。UBM可用于评估肿瘤的各种内部特征;然而,在没有组织学相关性的情况下很难做出明确诊断。